Roxithromycin-d7

• UNSPSC Description:

  Roxithromycin-d7 (RU-28965-d7) is the deuterium labeled Roxithromycin (HY-B0435)[1]. Roxithromycin (RU-28965) is a semi-synthetic macrolide antibiotic[2].

• Target Antigen:

  Antibiotic; Bacterial; Isotope-Labeled Compounds

• Type:

  Isotope-Labeled Compounds

• Related Pathways:

  Anti-infection;Others

• Field of Research:

  Others

• Purity:

  98.28

• Solubility:

  10 mM in DMSO

• Smiles:

  C[C@H]([C@H]([C@](O)(C[C@H](/C([C@@H]([C@H]([C@](O)([C@H](OC([C@@H]1C)=O)CC)C)O)C)=N\OCOC([2H])([2H])C([2H])([2H])OC([2H])([2H])[2H])C)C)O[C@H]2[C@@H]([C@H](C[C@H](O2)C)N(C)C)O)[C@@H]1O[C@H]3C[C@](C)([C@H]([C@@H](O3)C)O)OC

• Molecular Weight:

  844.09

• References & Citations:

  [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Clinical Information:

  No Development Reported